To calculate adjusted net income (loss), adjusted net income (loss) attributable to Boston Scientific common stockholders and adjusted net income (loss) per share, we exclude certain charges ...
GlobalData on MSN1d
Boston Scientific reports outcomes from trial of LAAC deviceThe trial met its primary safety and efficacy endpoints, demonstrating the device's superiority to oral anticoagulants.
Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Larry ...
We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...
20h
In a report released on November 15, David Rescott from Robert W. Baird maintained a Buy rating on Boston Scientific (BSX – Research Report), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback